Polaryx Therapeutics (PLYX) schedules 2026 virtual annual meeting and proposal deadline
Rhea-AI Filing Summary
Polaryx Therapeutics, Inc. determined that its 2026 Annual Meeting of Stockholders will be held virtually on September 10, 2026. Stockholders of record of the company’s common stock at the close of business on July 27, 2026 will be entitled to notice of and to vote at the meeting, subject to the company’s reserved right to change the record date, meeting date, or location.
Because no annual meeting was held in 2025, stockholder proposals and director nominations intended for inclusion in the proxy materials under Rule 14a-8 must be received by the company, attention Alex Yang at its Paramus, New Jersey address, by the close of business on July 27, 2026 and must comply with SEC rules, Nevada law and the company’s Amended and Restated Bylaws. Proposals or nominations received after that date will be considered untimely and will not be included or considered at the meeting.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.08, 8.01
2 items
Item 5.08
Shareholder Director Nominations
Governance
Shareholder nominations for board of directors under proxy access rules. Rarely used -- the underlying SEC rule was vacated.
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
Annual Meeting date: September 10, 2026
Record date: July 27, 2026
Proposal and nomination deadline: July 27, 2026
+1 more
4 metrics
Annual Meeting date
September 10, 2026
Scheduled date for the 2026 Annual Meeting of Stockholders to be held virtually
Record date
July 27, 2026
Close of business date determining stockholders entitled to notice and to vote at the meeting
Proposal and nomination deadline
July 27, 2026
Deadline for Rule 14a-8 stockholder proposals and director nominations for inclusion in proxy materials
Company phone number
(201) 940-7236
Registrant’s telephone number including area code
Key Terms
Annual Meeting of Stockholders, record date, proxy materials, Rule 14a-8, +2 more
6 terms
Annual Meeting of Stockholders financial
"the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”)"
record date financial
"Stockholders of record of the Company’s common stock at the close of business on July 27, 2026"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
proxy materials financial
"proposal considered for inclusion in the Company’s proxy materials for the Annual Meeting"
Proxy materials are the packet of documents sent to shareholders that explain items to be voted on at a company meeting and include the actual ballot or instructions for casting a vote. Think of them as a voting packet that lays out who’s running the company, major proposals (like pay, mergers, or board changes), and arguments for and against each item. Investors care because those votes shape corporate direction, affect risk and future profits, and can influence share value.
Rule 14a-8 regulatory
"pursuant to Rule 14a-8 under the Securities Exchange Act of 1934"
Rule 14a-8 is a U.S. Securities and Exchange Commission regulation that lets eligible shareholders put proposals on a public company’s proxy ballot for an annual meeting, provided they meet basic ownership and filing requirements. It matters to investors because it creates a formal way to raise governance or strategic issues and force a company-wide vote—like getting an item onto the agenda of a neighborhood association meeting once you’ve lived there long enough—so shareholders can push for change or influence management decisions.
Amended and Restated Bylaws regulatory
"Nevada corporate law and the Company’s Amended and Restated Bylaws"
A company’s amended and restated bylaws are its internal rulebook rewritten to include all changes in one updated document, replacing the old bylaws. For investors, this matters because the bylaws set how the board, shareholders and officers make decisions, hold votes and handle disputes; a new consolidated version can change voting rights, control mechanisms or procedures that affect corporate governance and the value or risk of an investment.
Emerging growth company financial
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
When will Polaryx Therapeutics (PLYX) hold its 2026 Annual Meeting of Stockholders?
Polaryx Therapeutics plans to hold its 2026 Annual Meeting of Stockholders virtually on September 10, 2026. The company will later provide the specific time and voting matters in its proxy statement filed with the SEC before the meeting.
What is the record date for voting at Polaryx Therapeutics (PLYX) 2026 Annual Meeting?
The record date is the close of business on July 27, 2026. Only stockholders of record of Polaryx Therapeutics’ common stock at that time will be entitled to receive notice of, and vote at, the 2026 Annual Meeting and any adjournments or postponements.
What is the deadline for Polaryx Therapeutics (PLYX) stockholder proposals and director nominations for the 2026 meeting?
Stockholder proposals and director nominations must be received by the close of business on July 27, 2026. Items received after that date will be considered untimely and will not be included in proxy materials or considered at the 2026 Annual Meeting.
Where must Polaryx Therapeutics (PLYX) stockholders send Rule 14a-8 proposals for the 2026 Annual Meeting?
Proposals must be delivered or mailed to Alex Yang, Polaryx Therapeutics, Inc., South Tower, 140 E Ridgewood Avenue, Suite 415, Paramus, NJ 07652. They must arrive by July 27, 2026 and comply with Rule 14a-8 and other applicable requirements.
What rules govern Polaryx Therapeutics (PLYX) stockholder proposals and director nominations for 2026?
Proposals and nominations must comply with SEC Rule 14a-8, Nevada corporate law, and Polaryx Therapeutics’ Amended and Restated Bylaws. Even if timely, items that do not meet these legal and governance requirements may not be eligible for inclusion in proxy materials.
Can Polaryx Therapeutics (PLYX) change the 2026 Annual Meeting date or record date?
Yes. The company expressly reserves the right to change the record date, meeting date, and meeting location for the 2026 Annual Meeting. Any such changes would affect which stockholders are entitled to vote and how the meeting is conducted.